Alimera stock
WebApr 6, 2024 · ALIMERA SCIENCES, INC. : Shareholders Board Members Managers and Company Profile US0162592028 MarketScreener Homepage Equities United States Nasdaq Alimera Sciences, Inc. Company ALIM US0162592028 ALIMERA SCIENCES, INC. (ALIM) Add to my list Report Summary Quotes Charts News Ratings Calendar … WebGet the latest Alimera Sciences Inc (ALIM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Alimera stock
Did you know?
WebAlimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. IR Contacts. Subscribe to … WebMar 24, 2024 · Get the latest news and real-time alerts from Alimera Sciences, Inc. (ALIM) stock at Seeking Alpha. Alimera Sciences, Inc. (ALIM) Latest Stock News Seeking …
WebAlimera Sciences Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Your browser of choice has not been tested for … WebMar 23, 2024 · Alimera Sciences Inc (ALIM) stock is trading at $1.42 as of 1:26 PM on Thursday, Mar 23, a rise of $0.07, or 5.19% from the previous closing price of $1.35. The stock has traded between $1.42 and $1.46 so far today. Volume today is less active than usual. So far 2,509 shares have traded compared to average volume of 11,027 shares.
WebApr 14, 2024 · Alimera Sciences Inc (ALIM) stock is higher by 9.95% while the S&P 500 has fallen -0.53% as of 12:03 PM on Friday, Apr 14. ALIM is up $0.20 from the previous …
WebALIM Stock 12 Months Forecast. $9.00. (533.80% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Alimera in the last 3 months. The average price target …
WebAug 9, 2024 · ATLANTA, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences Europe Limited (“Alimera”), a wholly owned subsidiary of Alimera Sciences, Inc., and Tanner Pharma UK Limited (“Tanner”) announced... agenzia delle entrate riscossioni modulisticaWebAlimera Sciences Inc (ALIM) Stock Price & News - Google Finance Dow Futures $32,276.00 +0.053% +$17.00 S&P Futures $3,929.00 +0.23% +$9.00 Nasdaq Futures … agenzia delle entrate riscossioni casertaWebAlimera Sciences, Inc. (ALIM) Stock Price, News, Quote & History - Yahoo Finance Alimera Sciences, Inc. (ALIM) NasdaqGM - NasdaqGM Delayed Price. Currency in USD … Alimera Sciences, Inc. 6310 Town Square Suite 400 Alpharetta, GA 30005 United … Find out all the key statistics for Alimera Sciences, Inc. (ALIM), including … Alimera Sciences, Inc. (NASDAQ:ALIM) Q3 2024 Earnings Call Transcript … Find the latest Alimera Sciences, Inc. (ALIM) stock discussion in Yahoo … Alimera Sciences, Inc. (ALIM) NasdaqGM - NasdaqGM Real Time Price. Currency … See Alimera Sciences, Inc. (ALIM) stock analyst estimates, including earnings … Get the detailed quarterly/annual income statement for Alimera Sciences, Inc. … Alimera Improves Capital Structure, Strengthens Balance Sheet and … Find the latest Alimera Sciences, Inc. (ALIM) stock quote, history, news and … The latest news and headlines from Yahoo! News. Get breaking news stories and in … md cd ダビング キタムラWebMar 27, 2024 · -Alimera Sciences Inc ( ALIM) stock is trading at $1.76, an increase of $0.41, or 30.24%, on high volume. Alimera Sciences Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $6.75. Alimera Sciences Inc next reports earnings on March 30. mdaとは 秘密WebAlimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better … agenzia delle entrate riscossioni prenotaWebApr 11, 2024 · ALIM Alimera Sciences, Inc. Stock Price & Overview 3.98K followers $1.64 0.00 ( 0.00%) 3:55 PM 03/21/23 NASDAQ $USD Market Close Summary Ratings Financials Earnings Dividends Valuation... agenzia delle entrate risposta interpelloWebMar 31, 2024 · 12.90% of Alimera Sciences stock is owned by insiders. Which Alimera Sciences insiders have been buying company stock? The following insiders have purchased ALIM shares in the last 24 months: James R Largent ($43,100.00), John Philip Jones ($20,400.00), and Richard S Eiswirth Jr ($158,950.25). mdcb12 マサル